Monthly updated database of 1,500+ independent drug sales forecasts.
All marketed and pipeline products searchable by 15 key market dimensions including company, therapy area, ATC code and lifecycle stage.
Detailed historical and forecast company financials including operating cost and profit data.
According to a client, "PVX offers more in terms of forecasting and market assessment than any other tool on the market. Period."
HIM 500 Sample Evaluation Matrix This is a complete
PharmaVitae Explorer Brochure 09
1. PharmaVitae
Explorer
Contact us for a FREE DEMO | demo@datamonitor.com
Find out how you can uncover pharmaceutical market new opportunities with a demonstration of the Global Retail Database. Explorer.
global retail trends and trends and new opportunities with a demonstration of the PharmaVitae
2. Introducing the PharmaVitae Explorer
The PharmaVitae Explorer brings together the wealth of PharmaVitae sales, pipeline and financial data on the top 50
pharmaceutical and biotechnology companies in a single easy-to-use online interface.
The PharmaVitae Explorer provides:
Monthly updated database of 1,500+ independent
drug sales forecasts.
All marketed and pipeline products searchable
by 15 key market dimensions including company,
therapy area, ATC code and lifecycle stage.
Detailed historical and forecast company
financials including operating cost and profit data.
With the PharmaVitae Explorer you can:
View and analyze your results in seconds using
online interactive tables and charts.
Export your findings to Excel, PowerPoint or
Word with automatic referencing and sourcing.
Use the PharmaVitae Explorer to analyze sales, pipelines, companies, financials and M&A permutations:
Sales Analysis Pipeline Analysis Company Analysis Financial Analysis M&A Analysis
Explore 1,500+ drugs by: Profile Phase Assess the sales, Compare multiple Perform
company, therapy area, I-III pipelines and pipeline and financial companies by financial a virtual
ATC code, molecule type marketed product performance of a metrics such as R&D merger of two
and lifecycle stage. portfolios. single company. spend, profit and ROI. companies.
Contact us for a FREE DEMO | demo@datamonitor.com
Find out how you can uncover pharmaceutical market trends and new opportunities with a demonstration of the PharmaVitae Explorer.
3. Intuitive workflow
The PharmaVitae Explorer allows you to investigate the dynamics of the pharmaceutical industry in four simple steps:
Step 1: ChooSe your AnAlySiS type Step 2: BuilD your SeArCh
Choose which of the five types of analysis you wish to perform Select the combination of search terms you wish to use
Sales Analysis: 1,500+ drugs by 15 The column on the left displays 16
dimensions including company, therapy individual search terms.
area and ATC. Clicking on each search term displays
Pipeline & Product Analysis: Phase I-III additional criteria in the central column.
pipelines and marketed product portfolios. All of your selections are shown in the
Company Analysis: Sales, pipeline and review column on the right. You can
financials of a single company. remove variables selected by clicking on
Financial Analysis: Compare financials of the orange ‘x’.
multiple companies. Before proceeding to view results decide
M&A Analysis: Perform virtual mergers. how you want to view the data: value,
growth rate, market share or company
focus.
Step 3: VieW your tABle of reSultS Step 4: ChArt AnD eXport your reSultS
View your results as rows of individual products or grouped by categories Analyze your results using the interactive chart
View your table of results with a row for View your results as an interactive chart.
each product that matches your search
query. Select whether you wish to chart results as
a series of individual products or grouped by
Each product name is a hyperlinked to a categories including company, therapy area
product detail page. or ATC.
The ‘display options’ tab allows you to Choose between three complementary
group your product results by categories forecast methodologies.
including company, therapy area or ATC.
Export sourced tables and charts in your
‘Display options’ also allows you to change preferred format.
currency, source data type and time period.
Contact us for a FREE DEMO | demo@datamonitor.com
Find out how you can uncover pharmaceutical market trends and new opportunities with a demonstration of the PharmaVitae Explorer.
4. Consistent workflow across all analysis types
Step 1: Step 2: Step 3: Step 4:
Analysis Type Search View Results Chart Results
Chart sales
Define market View historical and
of market
segment of interest forecast sales of market segment
segment
Sales Analysis
View detailed
View and compare Chart and
Select set of forecasts and
characteristics of analyze the
products of interest assumptions for
Pipeline & multiple products product pipeline
Product Analysis a single product
View sales,
View and compare Chart sales and
Select set of pipelines and
characteristics of financials for a
companies of interest financials for a
multiple companies single company
Company Analysis single company
Chart and
Select set of View and compare financial line items compare financial
companies of interest across multiple companies items for multiple
Financial Analysis companies
Chart sales and
View sales and characteristics
Pick two companies to merge characteristics of
of merged company
merged company
M&A Analysis
Contact us for a FREE DEMO | demo@datamonitor.com
Find out how you can uncover pharmaceutical market trends and new opportunities with a demonstration of the PharmaVitae Explorer.
5. PharmaVitae Explorer - supports key decisions throughout your organization
M&A/Strategic Planning Competitive Intelligence
Map the growth rate landscape of Benchmark historical and forecast
/ Co
&Aegic
sales performance of key competitors
Intempe
the industry.
against your own company.
Identify high growth segments to M at ing llig ti
enter and low/negative growth r nn e Explore the knock-on consequences
a
tiv ce
Pl t
segments to exit. of competitor M&A.
S
e
n
Analyze the impact of hypothetical
M&As.
Market Research/Forecasting
Examine sales forecasts for any user-
Fo search/
asting
Corpo nce
defined market segment.
Re arket
Fina
Independently validate or challenge
your internal assumptions.
rec
M
rat
Corporate Finance
e
Compare historical and forecast cost
structures across peers.
Access historical and forecast Business
Devel
opment/
profitability data.
Business Development/Licensing
Licencing Identify product licensing/partnering
opportunities.
Assess the future sales value of any deal
targets.
Contact us for a FREE DEMO | demo@datamonitor.com
Find out how you can uncover pharmaceutical market trends and new opportunities with a demonstration of the PharmaVitae Explorer.
6. PharmaVitae Explorer - Quality data
Our portfolio of data is based on years of primary and secondary research, allied with our analysts’ own unique knowledge
of the pharmaceutical industry. The PharmaVitae Explorer contains sales forecasts for 1,500+ drugs and detailed financials
for the top 50 pharmaceutical and biotechnology companies.
Company coverage Data types
The PharmaVitae Explorer covers the following 50 companies. Users have the
option of viewing recent mega-mergers as either separate or combined entities: Historical and Forecast Sales Data
• Company-reported historical sales data for 1,500+ drugs
Abbott Eisai Nycomed
(annual and quarterly since 2001).
Actelion Eli Lilly Otsuka
• Seven-year sales forecasts for 1,500+ drugs created using three
Alcon Forest Pfizer
complementary methodologies:
Allergan Genentech Roche
• Datamonitor projections from historical company-reported sales data;
Amgen Genzyme Sandoz
• Datamonitor projections from historical IMS sales data;
Astellas Gilead Sanofi-Aventis
• Analyst consensus forecasts.
AstraZeneca GlaxoSmithKline Schering-Plough
Barr Johnson & Johnson Sepracor
Bayer King Servier
Historical and Forecast Financial Data
Biogen Idec Lundbeck Shire
Boehringer Ingelheim Menarini Solvay
Bristol-Myers Squibb Merck & Co. Takeda • Company-reported historical financial data for top 50 companies
Celgene Merck KGaA Teva (annual and quarterly since 2001).
Cephalon Mitsubishi Tanabe UCB • Profit and loss;
Chugai Mylan Watson • Balance sheet;
Daiichi Sankyo Novartis Wyeth • Cash flow statement.
Dainippon Sumitomo Novo Nordisk • Seven-year operating cost and profit forecasts for top 50 companies.
Contact us for a FREE DEMO | demo@datamonitor.com
Find out how you can uncover pharmaceutical market trends and new opportunities with a demonstration of the PharmaVitae Explorer.
7. Datamonitor UK | Charles House, 108-110 Finchley Road, London NW3 5JJ, United Kingdom | t: +44 20 7675 7000 | e: ukinfo@datamonitor.com
Datamonitor USA | 245 Fifth Avenue, 4th Floor, New York NY10016, United States | t: +1 212 686 7400 | e: usinfo@datamonitor.com
Contact us for a 46, 2 Park Street, Sydney, NSW 2000, Australia | t: +61 2 8705 6900 | e: apinfo@datamonitor.com
Datamonitor Asia Pacific | Level FREE DEMO | demo@datamonitor.com
Find out how| you can uncover pharmaceutical Tokyo 104-0061, Japan | t: +81 3 new opportunities with a demonstration of the PharmaVitae Explorer.
Datamonitor Japan Da Vinci Ginza East 7th Floor, 5-14-5 Ginza, Chuo-ku, market trends and 5148 7670 | e: jpinfo@datamonitor.com